Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nordhealth As | Oslo | Salute | Attrezzature e forniture medicali | 3,48 Mrd NOK | -30,9x | 44 NOK | 12,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,5% Rialzo | Fai l’upgrade a Pro+ | ||
Medistim | Oslo | Salute | Attrezzature e forniture medicali | 2,78 Mrd NOK | 27,8x | -2,04 | 152 NOK | 2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,2% Rialzo | Fai l’upgrade a Pro+ | |
Photocure | Oslo | Salute | Prodotti farmaceutici | 1,33 Mrd NOK | 94,2x | 0,66 | 49,20 NOK | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Vistin Pharma ASA | Oslo | Salute | Prodotti farmaceutici | 1,04 Mrd NOK | 17,2x | 0,45 | 23,40 NOK | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Nykode Therapeutics | Oslo | Salute | Ricerca medica e biotecnologica | 875,14 Mln NOK | -1,9x | -0,31 | 2,68 NOK | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thor Medical | Oslo | Salute | Ricerca medica e biotecnologica | 854,89 Mln NOK | -64,8x | 3,64 NOK | -11% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Arcticzymes Tech | Oslo | Salute | Ricerca medica e biotecnologica | 650,65 Mln NOK | 146,7x | -1,79 | 12,74 NOK | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,6% Rialzo | Fai l’upgrade a Pro+ | |
Gentian Diagnostics | Oslo | Salute | Attrezzature e forniture medicali | 616,89 Mln NOK | 275x | 1,95 | 40 NOK | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Omda AS | Oslo | Salute | Attrezzature e forniture medicali | 582,84 Mln NOK | 8,4x | 0,03 | 28,70 NOK | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Navamedic | Oslo | Salute | Prodotti farmaceutici | 452,17 Mln NOK | 15,9x | 25,60 NOK | 4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 44,5% Rialzo | Fai l’upgrade a Pro+ | ||
Bergenbio | Oslo | Salute | Ricerca medica e biotecnologica | 424,80 Mln NOK | -2,3x | -0,03 | 10,87 NOK | -4,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ContextVision AB | Oslo | Salute | Attrezzature e forniture medicali | 399,22 Mln NOK | 18,1x | -0,44 | 5,16 NOK | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,3% Rialzo | Fai l’upgrade a Pro+ | |
Lytix Biopharma AS | Oslo | Salute | Ricerca medica e biotecnologica | 374,06 Mln NOK | 7,54 NOK | -5,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Lifecare | Oslo | Salute | Ricerca medica e biotecnologica | 229,85 Mln NOK | 0,51 | 14,50 NOK | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
INIFY Laboratories | Oslo | Salute | Attrezzature e forniture medicali | 202,66 Mln NOK | 4,48 NOK | 12% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Exact Therapeutics AS | Oslo | Salute | Ricerca medica e biotecnologica | 192,48 Mln NOK | -3,5x | 0,09 | 6 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Observe Medical | Oslo | Salute | Attrezzature e forniture medicali | 93,36 Mln NOK | -1x | -0,03 | 0,38 NOK | -2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ultimovacs | Oslo | Salute | Ricerca medica e biotecnologica | 68,19 Mln NOK | -0,4x | -0,02 | 1,98 NOK | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PCI Biotech | Oslo | Salute | Ricerca medica e biotecnologica | 55,99 Mln NOK | -3,4x | -0,08 | 1,50 NOK | 3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arctic Bioscience AS | Oslo | Salute | Prodotti farmaceutici | 50,49 Mln NOK | -7,2x | 0,05 | 1,99 NOK | 2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Circio Holding | Oslo | Salute | Ricerca medica e biotecnologica | 31,06 Mln NOK | 0,6x | 0,03 | 0,74 NOK | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SoftOx Solutions | Oslo | Salute | Ricerca medica e biotecnologica | 22,63 Mln NOK | -0,1x | 0,010 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Codelab Capital AS | Oslo | Salute | Attrezzature e forniture medicali | 19,69 Mln NOK | 0,06 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |